Nick McIlwain – Philadelphia Man of the Year Candidate – Leukemia & Lymphoma Society (LLS)

May 52022 - June 12022

Nick’s Man of the Year Fundraiser

Please join Nick in supporting The Leukemia & Lymphoma Society (LLS) by making a donation to his fundraising campaign for Man & Woman of the Year!

Fundraiser Info

Nick has been involved in the local LLS Eastern Pa-Delaware Region for several years and in 2022, they have nominated him to be their Man of the Year.

A few years ago, Nick’s nephew, Luke, was diagnosed with pre-B ALL (Acute Lymphoblastic Leukemia) but the good news is that he’s now happy and healthy and in remission! Luke has reached and passed end of treatment. He still does regular blood work and according to his oncologist, his blood is “perfect”.


Simply put, Luke wouldn’t be where he is without the tireless and unending support from the incredible team at LLS.

While Luke is doing well, so many people affected by Leukemia and Lymphoma continue to need your help. In fact, many LLS supported therapies not only help blood cancer patients but are also now used to treat patients with rare forms of stomach and skin cancers. AND they are now even in clinical trials for patients with lung, brain, breast, pancreatic and prostate cancers, too! This is great news and incredible progress. LLS funded drugs like targeted therapies and immunotherapies are quite literally saving thousands of lives every day. But they can’t do it without help from people like you and campaigns like this one, so if you can, please DONATE!

Stay tuned to the show and follow along on Nick’s social media accounts – Twitter and Instagram – as he posts info about events and ways you can participate in between now and June 1st.

Sign me up for the MMR VIP email newsletter!

Get the good stuff sent straight to your inbox, and be the first to know: concert presales, exclusive contests, and behind the scenes photos and video.

By clicking "Subscribe" I agree to the website's terms of Service and Privacy Policy. I understand I can unsubscribe at any time.